EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure
Regulation FD Disclosure
On January 25, 2019 we released the press release furnished herewith as Exhibit 99.1.
Section 9 – FINANCIAL STATEMENTS AND EXHIBITS
Financial Statements and Exhibits
Exactus, Inc. Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE ex99-1 Exhibit 99.1 Exactus Appoints New Members to Its Board of Directors Adds Expertise in Finance Healthcare & Operations Exactus Inc. (OTCQB: EXDI) a healthcare company pursuing opportunities in Hemp derived,…
To view the full exhibit click
About EXACTUS, INC. (OTCMKTS:EXDI)
Exactus, Inc. (Exactus), formerly Spiral Energy Tech, Inc., is a life science company. The Company will develop and commercialize Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a detection platform. The Company’s primary business focus will be the development and commercialization of the FibriLyzer and related technology licensed by Exactus. The Company’s products will employ a disposable test biosensor strip combined with a portable hand held detection unit that provides a result in approximately 30 seconds. The Company intends to file to gain regulatory approval and launch its products in the United States and Europe.